Content Type: Article

  • EU Shorting Threshold Lowered  to 0.1% from 31 January 2022

    EU Shorting Threshold Lowered to 0.1% from 31 January 2022

    ARTICLE / CLIENT ALERT

    EU Shorting Threshold Lowered to 0.1% from 31 January 2022

    January 12, 2022

    Read time: 4 min

    Key takeaways
    Overview

    From 31 January 2022 (“Implementation Date”), the initial threshold for notification of significant net short positions in EU-traded stocks will be lowered from 0.2% to 0.1% of a company’s issued share capital. Asset managers with net short positions will need to adjust their procedures and systems to comply with the  new requirements.

    The Implementation Date follows the publication of a Delegated Regulation[1] in the European Union’s Official Journal on 11 January 2022 amending the Short Selling Regulation[2].

    Any holder of a net short position (whether established before, on or after the Implementation Date) in a company admitted to trading on an EU “trading venue”[3] must notify the relevant competent authority[4] if the net short position amounts to 0.1% or more of a company’s issued share capital. This brings the EU’s initial reporting threshold in line with the current UK threshold, which already stands at 0.1%.

    The Delegated Regulation does not alter any other requirements of the Short Selling Regulation; incremental notification thresholds remain the same. These will be triggered for each 0.1% above or below the initial threshold. For asset managers with positions across different funds and portfolios, net short positions must be calculated for each account and then aggregated where the same investment strategy (i.e., being short or long) is pursued in relation to a particular issuer[5] across more than one account.  

    Background to the Lower Threshold

    The transition to a permanent lower threshold follows the prior instances of European Securities and Markets Authority’s (“ESMA”) temporarily lowering the reporting threshold at the start of COVID-19 pandemic to address market volatility and increase transparency.

    The threshold was initially lowered to 0.1% from 16 March 2020 and renewed three times until 19 March 2021 on the basis of emergency powers[6]. Since 20 March 2021, the threshold has reverted to 0.2%.

    ESMA’s analysis of the reporting received during this time lead to a request to the EU Commission to issue permanent rules, because its monitoring highlighted a large number of net short positions between 0.1% and 0.2%. The regulator hopes that greater transparency of net short positions will improve the capacity of ESMA and national competent authorities to act quickly in case more stringent action is needed in the future to control turbulent market conditions.

    Authored by Anna Maleva-Otto and David Soerensen.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Commission Delegated Regulation (EU) 2022/27 of 27 September 2021 amending Regulation (EU) No 236/2012 of the European Parliament and of the Council as regards the adjustment of the relevant threshold for the notification of significant net short positions in shares.

    [2] Regulation (EU) No 236/2012 of the European Parliament and of the Council of 14 March 2012 on short selling and certain aspects of credit default swaps (“Short Selling Regulation”)

    [3] See FIRDS database maintained by ESMA. See also List of exempted shares for dually-listed shares whose principal market is outside the EU.

    [4] The “relevant competent authority” means the authority of the most relevant market in terms of liquidity for the financial instrument in question or the authority of the Member State in which the financial was first admitted to trading on a trading venue, see the Short Selling Regulation Article 2(1)(j)(v) and (vi).

    [5] Article 12(3) in Regulation (EU) No 918/2012.

    [6] “ESMA to Allow Decision on Reporting of Net Short Position of 0.1% and Above to Expire,” ESMA, 15 March 2021, available here.


    This communication is issued by Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP and Schulte Roth & Zabel International LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure

    Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure

    ARTICLE / CLIENT ALERT

    Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure

    January 10, 2022

    Read time: 13 min

    Key takeaways
    Overview

    On January 6, 2022, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule regarding Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, marking the Biden administration’s first proposed rule on these topics. The proposed rule includes proposed changes to the manner in which pharmacy price concessions are accounted for in the Part D benefit, the timing of network adequacy reviews for Medicare Advantage Organization (MAO) applicants, and new rules regarding oversight of third-party marketing organizations. The proposed rule also reverses course on some policy changes that were initiated under the prior administration, including changes related to medical loss ratio (MLR) reporting and past performance evaluations. The proposed rule includes proposed policy updates for Dual Eligible Special Needs Plans (D-SNPs) and a few provisions related to the ongoing COVID-19 public health emergency (PHE).

    Comments on the proposed rule are due by March 7, 2022. Stakeholders should expect additional policy and technical changes in the forthcoming advance notice, which should be released in early February.

    In depth

    Changing How Contingent Pharmacy Price Concessions Are Treated for Purposes of the “Negotiated Price”

    CMS proposes to change the way that pharmacy price concessions are factored into the Part D negotiated price.

    Part D beneficiary cost-sharing is based on the negotiated price that a Part D plan (or its pharmacy benefit manager) has negotiated with a pharmacy for the particular drug being dispensed. The negotiated price is also used to calculate other aspects of the Part D benefit. Currently, the term negotiated price is defined as the total amount a pharmacy and a plan have negotiated as the payment amount for a drug. It excludes dispensing fees as well as contingent amounts that may be later paid by the plan or the pharmacy if those amounts cannot reasonably be determined at the point of sale. These contingent amounts might include, for example, quality incentive payments to a pharmacy based on achievement of certain quality metrics or additional price concessions that the pharmacy may pay to the plan. As with other value-based payment arrangements, many pharmacy payment arrangements now commonly involve retrospective reconciliation after the end of a calendar year or other period. If a part of the plan’s payment to a pharmacy is unknown and cannot reasonably be determined at the point of sale, CMS’s current rules provide that those contingent amounts need not be factored into the negotiated price on which beneficiary cost-sharing is based. Rather, these amounts are later reported to the government through direct and indirect remuneration reporting and taken into account in final reconciliations between the government and Part D plans.

    In the proposed rule, CMS suggests a shift in this framework that would redefine the term “negotiated price” to mean the “lowest possible reimbursement” a pharmacy might receive, in total, for a particular drug. Under the proposed definition, the negotiated price would include:

    • All dispensing fees
    • All price concessions that might possibly be paid in the future by a pharmacy to a plan.

    Under this definition, the negotiated price would exclude:

    • Any additional contingent amounts that would increase the drug price (e.g., potential incentive payments the pharmacy may earn from the plan)
    • Any non-pharmacy price concessions (e.g., manufacturer rebates) that are passed through to the beneficiary at the point of sale.

    The proposed change would not impact how the “negotiated price” is determined for applicable drugs in the coverage gap, which is subject to a separate regulatory definition at 42 CFR § 423.2305.

    CMS’s proposed change to the negotiated price definition would reduce cost-sharing for certain Medicare beneficiaries at the point of sale. As noted by CMS, it would also increase premiums across the Part D program. Specifically, CMS anticipates that, over the next 10 years, beneficiary cost-sharing liability would decline by $21.3 billion, while government spending would rise by $40 billion following enactment of this proposal. CMS estimates that the negotiated price change in the proposed rule would also result in $14.6 billion in cost savings for manufacturers by slowing the progression of beneficiaries through the Part D benefit.

    Provider Networks in Place at the Time of Application, Subject to 10 Percentage Point Credit

    MAOs must maintain provider networks that meet specific time and distance criteria established by CMS. Prior to the establishment of a new tool, the Network Management Module, several years ago, CMS typically only evaluated MAO networks upon initial application for an MA contract and upon a service area expansion. Following establishment of the Network Management Module, CMS began monitoring network adequacy more regularly. However, in the context of a new application or a service area expansion, CMS’s review of network adequacy has always occurred on a delayed timeframe following CMS’s review of other application criteria. CMS proposes to change this framework.

    CMS proposes to require the submission of provider contract information to CMS at the time of application submission, in mid-February. CMS also proposes to adopt regulations explicitly permitting it to deny applications based on an applicant’s failure to meet network adequacy criteria. This proposed change would be effective for the Contract Year 2024 application cycle, for which applications will be due in February 2023.

    To ease the difficulty of contracting with provider organizations so far in advance of the plan year, CMS proposes to provide applicants with a temporary 10 percentage point credit towards the percentage of beneficiaries residing within the published time and distance standards for all of the combinations of county designations and provider/facility types. This temporary credit would only be available until the beginning of the applicable plan year, at which time plans would be required to meet the full network adequacy criteria.

    Many new and expanding MAOs have had difficulty obtaining provider contracts before they are approved by CMS to offer a plan in the designated region. Historically, the delayed timeframe for network review mitigated this issue to some degree. Some MAOs may find it challenging to establish networks by February, even with the 10 percentage point credit. Because of different market competition dynamics throughout the country, the impact of the proposed change may vary by geography.

    Reviving Past Performance Methodology for Application Denials

    Prior to 2021, CMS utilized a subregulatory methodology for assessing the past performance of entities seeking new MA or Part D contracts or service area expansions. The methodology assigned negative “points” to applicants based on a variety of factors, such as quality star ratings, notices of noncompliance, intermediate sanctions and negative net worth, associated with either the applicant’s or its affiliated organizations’ performance in the MA and Part D programs. In 2021, CMS rescinded the prior past performance methodology and enacted a regulation stating that an application may be denied based on past performance related to intermediate sanctions and failure to maintain fiscal soundness.

    CMS now proposes to codify in regulation additional bases that would support an application denial, including a new points-based system for compliance actions. Specifically, the proposed regulations would permit CMS to deny an application based on:

    • A quality star rating of 2.5 or fewer stars during the applicable review period
    • Failure to maintain a fiscally sound operation or filing for bankruptcy
    • Assignment of more than 13 “points” in connection with “compliance actions,” including notices of noncompliance (1 point), warning letters (3 points) and corrective action plans (6 points).

    CMS requests comment on alternative methodologies for counting compliance actions and on how to incorporate civil money penalties into the methodology in the future.

    Additional Oversight Obligations in Connection with Third-Party Marketing Organizations

    Following up on new subregulatory guidance issued in October 2021, CMS proposes to codify additional regulatory requirements related to third-party marketing organizations (TPMOs). While CMS’s proposed definition of TPMO is broad, CMS appears to be most focused on entities that engage in lead generation activities under contracts with MA and Part D plan sponsors as well as their first-tier, downstream and related entities (FDRs). The proposed new requirements include:

    • Use of a standardized disclaimer on certain TPMO materials
    • Mandated contract terms between plans (or their FDRs) and TPMOs, including beneficiary disclosure and call recording obligations
    • Plan responsibility for “ensuring” the compliance of the TPMOs with which they (or their FDRs) do business, even if the TPMO is not considered an FDR.

    Given the breadth of the proposed definition of TPMO, the proposed changes may implicate a broad range of marketing organizations. If finalized, these changes would result in contract updates and new oversight obligations for plan sponsors and their FDRs.

    Other Proposals Impacting MA and Part D Plans

    • Reinstatement of Detailed MLR Reporting: Under the prior administration, MLR reporting was significantly reduced, such that only a handful of data elements were required to be submitted to the government. CMS now proposes to reverse course on that change and reinstate the prior, more detailed, reporting requirements, beginning with MLR reporting for Contract Year 2023. CMS proposes to expand the MLR report to include expenditures related to certain supplemental benefits, such as dental, vision, hearing, transportation, remote access technologies, out-of-network services, meals and acupuncture.
    • Codification of Marketing and Communication Rules: CMS proposes to reinstate the requirement that MA and Part D plans include a multi-language insert in CMS-required materials. CMS also proposes to codify several existing subregulatory requirements, including those relating to ID cards, disclaimers for Part D sponsors with limited access to preferred cost-sharing, and website-posted content related to the appointment of a representative and enrollment.
    • Calculation of Contract Year 2023 Star Rating Measures: CMS proposes to allow MAOs with at least 25% of their enrollees in individual assistance areas affected by the COVID-19 pandemic to receive the higher of their Contract Year 2022 or 2023 Star Ratings for three measures: Monitoring Physical Activity, Reducing the Risk of Falling and Improving Bladder Control.
    • Duration of Disaster and Emergency Policies: CMS clarified the timeframes during which special disaster and emergency requirements for MA plans apply. This provision relates to regulatory requirements for plans to cover services provided by non-contracted providers and to waive gatekeeper referral requirements, and does not explicitly apply to subregulatory flexibilities afforded to MA and Part D plans during the current PHE.

    Proposed Changes Specific to D-SNPs

    Consistent with the Biden administration’s focus on enhancing health equity and beneficiary protections, the proposed rule contains several proposals aimed at streamlining and simplifying D-SNP offerings, improving beneficiary engagement and addressing health equity:

    • Enrollee Participation in Plan Governance: Building on experience with other programs, such as the Medicare-Medicaid Financial Alignment Initiative and Programs of All-Inclusive Care for the Elderly, CMS proposes that MAOs offering one or more D-SNPs in a state would be required to establish and maintain one or more enrollee advisory committees to solicit direct input on ways to improve access to covered services, coordination of services and health equity. CMS has been exploring enrollee advisory committees in other contexts, including CMS Innovation Center models. Stakeholders should review this proposal and consider submitting their comments with that broader context in mind.
    • Standardizing Certain Questions Related to Social Determinants of Health on Health Risk Assessments (HRAs). Under current statute and regulation, SNPs are required to conduct an initial assessment and an annual reassessment of each enrollee’s physical, psychosocial and functional needs. This rule proposes that all SNPs, including D-SNPs, incorporate standardized questions on the topics of housing stability, food security and access to transportation as part of their HRAs. The questions would be further detailed through subregulatory guidance. CMS clarifies that SNPs would not be accountable for resolving all of the risks identified, but notes that current regulations require that the results of the HRAs be addressed in the individual’s care plan, which could include, for example, making an appropriate referral to a community resource. CMS proposes to begin enforcing this requirement in 2024 but also is considering a later date.
    • Refining Definitions for FIDE and HIDE SNPs: The proposed rule contains several definitional changes related to fully integrated dual eligible special needs plan (FIDE SNPs) and highly integrated dual eligible special needs plan (HIDE SNPs) to help differentiate various types of D-SNPs, clarify options for beneficiaries and improve care coordination. These changes would take place in 2025 and subsequent years to afford plans and states time to ensure compliance.
    • Additional Opportunities for Integration Through State Medicaid Agency Contracts: CMS proposes a new pathway for D-SNPs in states that require exclusively aligned enrollment (i.e., D-SNPs can only enroll full-benefit dual eligible individuals who receive Medicaid benefits from the SNP or an affiliated Medicaid managed care plan). When certain conditions are met, CMS proposes to permit an MAO to apply for a D-SNP-only contract using the existing MA application process. CMS indicates that if a state elects this option, CMS would provide greater transparency regarding quality performance, financial performance and provider networks.
    • Attainment of max out-of-pocket (MOOP) limit: MAOs are required to establish a limit on beneficiary out-of-pocket costs for Medicare Part A and B services. After that limit, the MAO must pay 100% of the service costs. Under current guidance, MAOs do not have to count Medicaid-paid amounts or unpaid amounts toward this limit. CMS believes that this approach disadvantages providers serving dual eligible individuals in MA plans, and proposes that the MOOP limit in an MA plan be calculated based on the accrual of all cost-sharing in the plan benefit, regardless of whether that cost-sharing is paid by the beneficiary, Medicaid or other secondary insurance or remains unpaid because of state limits on the amounts paid. CMS expects that this proposal would result in increased bid costs for the MOOP for some MA plans and that a portion of those higher bid costs would result in an increase in Medicaid spending of $3.9 billion over 10 years. This cost would be partially offset by a reduction in federal Medicaid spending of $2.7 billion and the portion of Medicare spending paid by beneficiary premiums, totaling $600 million over 10 years. CMS estimates a net 10-year cost of $614.8 million.

    Requests for Information

    The proposed rule also includes two requests for information and a request for feedback on D-SNP data collection efforts:

    • Prior Authorization for Hospital Transfers to Post-Acute Care Settings During a PHE: CMS seeks general feedback on how MAOs’ prior authorization requirements for patient transfers impact a hospital’s ability to furnish the appropriate care to patients in a timely manner during the PHE. CMS notes that while many plans relaxed prior authorization requirements in 2020, many MAOs reinstated these requirements in 2021. CMS now seeks information about the effects of relaxation and reinstatement of prior authorizations on patient transfers during the PHE.
    • Building Behavioral Health Specialties Within MA Networks: MAOs are currently required to meet network adequacy requirements in connection with behavioral health providers, but CMS now seeks to increase its understanding about issues related to access to behavioral health specialties for enrollees in MA plans. Specifically, CMS seeks stakeholder feedback on challenges MAOs face when building an adequate network of behavioral health providers.
    • Request for Comment on Data Notification Requirements for Coordination-Only D-SNPs: CMS seeks feedback on an existing regulation that requires certain D-SNPs to notify the state Medicaid agency or its designees regarding hospital and SNF admissions for at least one group of high-risk full-benefit dual eligibles, as determined by the state Medicaid agency. CMS is interested in any stakeholder experience with implementing the data notification requirements and suggested improvements.

    Please contact our team with any questions regarding the proposed rule.

    Authors

    Kate McDonald

    Partner

    Washington, DC

    Emily R. Curran

    Associate

    Washington, DC

    More insights

  • FinCEN Seeks Guidance on Applying Corporate Transparency Act Reporting Obligations to Trusts and Estates

    FinCEN Seeks Guidance on Applying Corporate Transparency Act Reporting Obligations to Trusts and Estates

    ARTICLE / CLIENT ALERT

    FinCEN Seeks Guidance on Applying Corporate Transparency Act Reporting Obligations to Trusts and Estates

    January 10, 2022

    Read time: 6 min

    Key takeaways
    Overview

    The Corporate Transparency Act (CTA), which requires corporations, limited liability companies and other similar entities to disclose beneficial ownership information to the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN), is expected to impose reporting obligations on certain types of trusts and various individuals related to trusts. However, the CTA does not explicitly address many types of trusts commonly used in US estate planning. In response, FinCEN recently released proposed regulations governing the CTA and has requested comments on how to apply the proposed regulations to certain kinds of trusts. This article provides a glimpse into how the CTA may apply to trusts and details timing and penalties for reporting to FinCEN.

    In depth

    THE CTA AND A NOTICE OF PROPOSED RULEMAKING

    On December 7, 2021, FinCEN issued a Notice of Proposed Rulemaking (NPRM) to administer the beneficial ownership information reporting provisions of the CTA. The CTA is designed to combat illicit activities such as tax fraud, money laundering and terrorist financing.

    Under the CTA, “reporting companies” must report certain identifying information of “beneficial owners” and “applicants” to FinCEN. The following information must be reported for each beneficial owner and applicant:

    1. Full legal name
    2. Date of birth
    3. Current residential address for a beneficial owner and current residential or business address for an applicant
    4. A unique identifying number from an acceptable identification document (e.g., a passport) or a FinCEN identifier
    5. A copy of the relevant identifying document.

    An applicant is the individual who files the document that forms the entity or first registers the entity to do business in the United States. A beneficial owner is an individual who (1) owns or controls at least 25% of a reporting company’s ownership interests or (2) exercises substantial control over the entity. The recently issued NPRM lays out how these reporting requirements may affect certain kinds of trusts, trust beneficiaries, trust settlors and trust officeholders. Review of subsequent developments, such as final regulations, is necessary to determine how the CTA will affect trusts overall.

    HOW THE CTA IMPACTS TRUSTS

    There are two ways that the CTA may apply to trusts: (1) individuals with power to dispose of assets of a trust that holds ownership interests of a reporting company may be considered as controlling the ownership interests held in trust, and, thus, be beneficial owners if such ownership interests amount to 25% or more of the entity’s ownership interests, and (2) business trusts, which include statutory trusts and Massachusetts trusts, may be considered reporting companies. FinCEN acknowledges that the framework of the CTA is not always clear with respect to trusts and has requested comments on the CTA’s applicability to trusts.

    As described above, individuals may hold ownership interests in reporting companies through trusts. A trust beneficiary will be considered as owning such ownership interests if they have the right to withdraw, or demand distribution of, substantially all of the assets from the trust or if they are the only allowable recipient of both income and principal from the trust. Settlors with the power to revoke the trust or to otherwise withdraw assets of the trust will also be considered as owning such interests. Trustees will be considered to control such interests if they can dispose of trust assets. Moreover, any individual related to a trust with the power to dispose of trust assets may be considered as holding ownership interests in reporting companies held by the trust. The reporting company would be required to report identifying information of any such beneficiary, settlor, trustee or other individual who is considered as owning 25% or more of its ownership interests through a trust.

    Domestic reporting companies include entities that are created by a filing with a secretary of state or similar office, and foreign reporting companies are entities formed under the laws of foreign countries and are registered to do business in the United States by the filing of a document with a secretary of state or similar office. Business trusts are created by filing a formation document with a secretary of state and are, therefore, likely to be considered reporting companies as indicated by the NPRM.

    TIMING AND PENALTIES

    Reporting companies that were formed before the effective date of the reporting regulations must submit the beneficial owner information to FinCEN no later than two years from the effective date of the final regulations. Any reporting company formed after the effective date of the regulations must submit the relevant information to FinCEN within 14 days of formation. FinCEN invites comments on the timing of the effective date of the final regulations.

    Failure to provide beneficial ownership information to FinCEN under the CTA may result in both civil and criminal penalties. An individual or entity that fails to provide the required information will be liable for a civil penalty of up to $500 for each day a violation continues and may be fined up to $10,000 and imprisoned up to two years for a criminal violation.

    A REQUEST FOR COMMENTS

    FinCEN has requested comments on the following topics related to trusts:

    • Whether other types of trusts exist, besides business trusts (statutory trusts or Massachusetts trusts), that are created by the filing of a document with a secretary of state or similar office
    • The existence of data sources to determine the total number of trusts and what portion of the total are created or registered with a secretary of state or similar office.

    FinCEN will be accepting comments until February 7, 2022.

    Continued monitoring is required to determine how CTA reporting requirements will ultimately apply to trusts in the near future.

    Authors

    Michael Silva

    Partner

    Miami

    More insights

  • New Year, New Employment and Benefits Developments for Employers

    New Year, New Employment and Benefits Developments for Employers

    ARTICLE / CLIENT ALERT

    New Year, New Employment and Benefits Developments for Employers

    January 10, 2022

    Read time: 16 min

    Key takeaways
    Overview

    As the new year begins, in addition to the recent COVID-19 related developments (discussed here), employers should be aware of the following changes to ensure continuing compliance with federal, state and local laws and regulations. Employers should also be aware of the amendment to the New York Whistleblower Protection Law, previously discussed here, that will go into effect on Jan. 26, 2022.

    Privacy Notification Law

    A new New York State law, which goes into effect on May 7, 2022, requires employers to both notify and obtain the acknowledgment of new hires if the employer monitors telephone, email or the Internet. The notice to new hires needs to advise “that any and all telephone conversations or transmissions, electronic mail or transmissions, or internet access or usage by an employee by any electronic device or system, including but not limited to the use of a computer, telephone, wire, radio or electromagnetic, photo-electronic or photo-optical systems may be subject to monitoring at any and all times and by any lawful means.” The notice needs to be in writing, in an electronic record, or in an another electronic form and must be acknowledged by the employee either in writing or electronically. Employers must also post the notice of electronic monitoring in a conspicuous place which is readily available for viewing by employees. The new law does not apply to processes that are designed to manage the type or volume of incoming or outgoing email, voicemail or internet usage solely for the purpose of system maintenance and/or protection, rather than to target an individual. Employers found to be in violation of this law will be subject to a maximum civil penalty of $500 for the first offense, $1,000 for the second offense and $3,000 for the third and each subsequent offense.

    New York City Law Targeting Bias in Hiring

    A new New York City Council law goes into effect on Jan. 1, 2023. The law affects New York City employers that use automated employment decision tools as part of their hiring practices. The term “automated employment decision tool” refers to technology that uses machine learning, statistical modeling, data analytics or artificial intelligence to score or classify job seekers and replaces some discretionary decisions by employers.

    The law prohibits New York City employers from using automated employment decision tools to promote or screen job candidates, unless certain criteria have been met. The tool must be subject to a “bias audit,” conducted no more than a year before the use of the tool. Completing a “bias audit” will entail having an impartial evaluation conducted by an independent auditor. Bias audits must test, at minimum, whether an employer’s automated employment decision tool may have a disparate impact on the basis of race, sex or other protected categories. Employers must make a summary of the results of the tool’s most recent bias audit, as well as the distribution date of said tool, publicly available on the employer’s website.

    In addition, employers will need to adhere to several notification requirements. Employers must notify any candidate residing in New York City that an automated employment decision tool will be used in connection with the candidate’s evaluation, along with the job qualifications and characteristics that the tool will use. Notice must be given no less than ten business days before each use, allowing a candidate to request an alternative selection process or accommodation. Additionally, if an employer’s website does not disclose information about the type of data collected for the tool, that data’s source and the employer’s data retention policy, employers must provide that information within 30 days in response to a candidate’s written request. Penalties for violating the law are $500 for first-time violations and up to $1,500 for repeat offenses.

    Guidance Addressing Legalization of Cannabis

    The New York State Department of Labor (“NYDOL”) issued guidance to address questions related to the Marijuana Regulation and Taxation Act (“MRTA”), which authorized recreational use of cannabis. The guidance does not address medical use of cannabis.

    MRTA amended Section 201-D of the New York Labor Law and prohibits employers from discriminating against employees based on an employee’s legal use of cannabis outside of the workplace, outside of work hours and without use of the employer’s equipment or property. An employer may take action when an employee, while working, manifests specific “articulable symptoms” of cannabis impairment that decrease the employee’s work performance or that interfere with the employer’s obligation to provide a safe workplace. These articulable symptoms are “objectively observable indications that the employee’s performance of the duties of their position are decreased or lessened” and do not include signs of use that do not indicate impairment on their own, such as the odor of cannabis or a positive drug test.

    Employers are allowed to prohibit cannabis during “work hours,” meaning all time that an employee is working, including breaks and when the employee is on call, even if the employee leaves the worksite. Regardless of “work hours,” employers may prohibit employees from bringing cannabis onto the employer’s property, including rented space, company vehicles[1] and areas typically used by employees such as lockers and desks. An employee’s private residence being used for remote work is not a worksite within the meaning of the statute.

    An employer may not require employees to agree to not use cannabis or prohibit its use outside of the workplace. Employers are prohibited from drug testing employees for cannabis unless federal or state law requires doing so or makes it a mandatory requirement of the position.

    DHS Extends Form I-9 Requirement Flexibility

    On Dec. 20, 2021, Department of Homeland Security (DHS) and U.S. Immigration and Customs Enforcement (ICE) announced a further extension of the temporary guidance until April 30, 2022. This guidance permits flexibility in complying with requirements related to Form I-9, Employment Eligibility Verification, due to COVID-19.

    The requirement that employers inspect new hires’ Form I-9 identity and employment eligibility documentation in-person now applies only to those employees who physically report to work at a company location on any regular, consistent or predictable basis. For employees that do not work in person, employers must inspect employment eligibility documents remotely and obtain, inspect and retain copies of the documents. Once normal operations resume, all employees that were on-boarded using remote verification, must report to their employer within three business days for in-person verification of identity and employment eligibility documentation for Form I-9.

    New York Paid Sick Leave Guidance

    On Dec. 22, 2021, final regulations were released interpreting the New York Paid Sick Leave Law, a law we have previously discussed here and here. The final regulations adopted by the New York State Department of Labor (“NYDOL”) do not contain any changes from the proposed regulations, but include public comments and responses to such comments, that provide clarification of certain issues.

    With respect to required documentation for sick leave, the NYDOL stated that it will produce an “employee attestation template.” The NYDOL also clarified that an employer may not deny an employee leave while attempting to confirm the basis for the leave and documentation is not required for leave less than three days.

    Additionally, the NYDOL clarified that although the statute requires that employers carry over unused sick leave to the next calendar year, employers may (a) give employees the option to voluntarily elect to use and receive payment for paid sick leave prior to the end of a calendar year or carry over unused sick leave; or (b) only allow employees to carry over unused sick leave.

    Legislation Expanding New York State Paid Family Leave to Cover Siblings

    New York State’s Paid Family Leave legislation was amended to include caring for siblings with a serious health condition. The change will go into effect on Jan. 1, 2023. The New York Paid Family Leave Law, previously discussed here, here and here, currently provides employees with up to 12 weeks of paid leave to bond with a new child, to assist a family member who is on active military service or to care for a family member with a serious health condition. Eligible workers may take up to 12 weeks off at 67% of their pay (up to a cap) to care for family members in times of need. Before the latest change, “family member” included employees’ spouses, domestic partners, children and stepchildren, parents and stepparents, parents-in-law, grandparents and grandchildren. The new legislation will expand the definition of “family members” to include biological siblings, adopted siblings, stepsiblings and half-siblings. Family members can live outside of New York State, including outside of the country.

    Changes to the Connecticut Family and Medical Leave Act

    Several changes to the Connecticut Family and Medical Leave Act (“CTFMLA”) go into effect Jan. 1, 2022. Regarding eligibility, the modifications make the law applicable to employers with one or more employees working in Connecticut. Additionally, while eligible employees must be employed for at least three months immediately preceding their request for leave, the changes eliminate any hours worked requirement. Covered family members for “care” leave have been expanded from only spouse, child or parent, to also include grandparent, grandchild, sibling and any other “individual related to the employee by blood or affinity whose close association the employee shows to be the equivalent of those family relationships.”

    The CTFMLA changes permit eligible employees up to 12 weeks of leave (up to 16 weeks for military caregiver leave) in a 12-month period, as well an additional 2 weeks of leave that may be available for incapacitation during pregnancy.

    New York City Council Approves Bill Requiring Salary Ranges in Job Postings

    Following the lead of Connecticut, the New York City Council approved a bill that, if enacted, will amend the New York City Human Rights Law to make it an unlawful discriminatory practice for employers with four or more employees to not include the minimum and maximum salary offered in a job posting for any position located within New York City. The posted salary range for a position would need to “extend from the lowest to the highest salary the employer in good faith believes at the time of the posting it would pay for the advertised job, promotion or transfer opportunity.”

    The bill is pending either approval by the Mayor or enactment if no action by the Mayor by Jan. 13, 2022. The law will take effect 120 days after it is enacted. As the legislation notes that the New York City Commission on Human Rights (“NYCCHR”) “may take such actions as are necessary to implement this local law, including the promulgation of rules, before [the effective date of the law],” we expect the NYCCHR to provide guidance before the law would become effective.

    Employee Benefit Plan Considerations

    Over the past year, the Departments of Labor (“DOL”), the Treasury and Health and Human Services (“HHS”) (collectively, the “Departments”) have issued guidance impacting sponsors of retirement, health and welfare plans. In addition to this guidance, the Consolidated Appropriations Act of 2021 (“CAA”), which was signed into law on Dec. 27, 2020, provides additional relief for these plans, as well as educational assistance plans. Below we summarize some of the key requirements that are set to take effect in 2022. Plan sponsors should consider the effect that these changes will have on financial and administrative planning, now and in the coming years.

    Employer Nontaxable Benefits for Student Loan Repayment

    The CAA extends for five more years through Dec. 31, 2025 the ability for employers to treat student loan repayments as nontaxable fringe benefits under an educational assistance program that meets the rules under Code Section 127. Accordingly, employers may amend existing employer educational assistance programs or adopt a new program to pay or reimburse employees on a tax-free basis up to $5,250 per year for 2021 through 2025 (up to $26,250 total), saving the employer payroll taxes and saving the employee payroll and income taxes.

    Retirement Plan Amendments

    • Plan Amendments for Compliance with the SECURE Act. Plan amendments are required this year to comply with various changes under the SECURE Act, as previously discussed, including the new requirement to enroll part-time employees, the option for plan sponsors to increase the plan’s required beginning date for mandatory distributions to age 72, the option to allow penalty-free withdrawals for birth and adoption expenses and the new required disclosure rules regarding lifetime income.
    • Plan Amendments for Compliance with the CARES Act. Plan amendments are required this year to comply with various changes under the CARES Act, as previously discussed here, including Coronavirus-related distributions, increased loan limits and the temporary waiver of minimum required distributions in 2020.
    • Plan Amendments for Distribution and Loan Relief for Non-COVID Disasters. Plan amendments are required this year to comply with the non-COVID disaster relief under the CAA allowing distributions and loans similar to the CARES Act provisions for FEMA declared disasters (other than COVID-19) that were taken during the period from Jan. 1, 2020 through June 24, 2021. This relief included the right to take a plan distribution up to $100,000 without tax penalties, the ability to repay hardship distributions taken to purchase or construct a principal residence and loan relief such as an increase in the maximum loan amount from $50,000 to $100,000 and a delay of one-year for loan repayments. For plans that elected to allow these distributions and loans, amendments are due by the end of the 2022 Plan Year.
    • Plan Amendments for Coronavirus-Related Distributions from Money Purchase Plans. The CAA extended the COVID-19 in-service distribution relief under the CARES Act to retroactively apply to money purchase pension plans that had mistakenly allowed for such distributions during 2020. For money purchase plans that elected to allow such in-service distributions, amendments are due by the end of the 2022 Plan Year.
    • Plan Amendments for Compliance with the New Minimum Required Distribution Tables. Beginning Jan. 1, 2022, defined contribution plans, including 401(k) plans, profit sharing plans and 403(b) plans, have to update the life expectancy and distribution tables that are used to calculate required minimum distributions.
    • Partial Plan Termination Relief. The CAA provides relief for employers with calendar year plans from the partial plan termination rule that would otherwise require 100% vesting for turnover due to the economic impact of the COVID-19 pandemic. Specifically, a retirement plan will not be treated as having incurred a partial plan termination for any plan year that included the period beginning March 13, 2020 and ending March 31, 2021, provided that the number of active participants covered on March 31, 2021 was at least 80 percent of the number of active participants covered on March 13, 2020. Thus, employers who rehired a substantial number of laid off employees will not have to fully vest participants under the partial plan termination rule.

    No Surprises Act

    The No Surprises Act, which is a part of the CAA, protects patients against surprise billing from providers for certain out-of-network services. The No Surprises Act applies to both self- and fully-insured grandfathered and non-grandfathered health plans, but does not apply to retiree-only plans, flexible spending and health reimbursement arrangements or stand-alone excepted benefit plans. Certain parts of the No Surprises Act become effective for the first plan year beginning on or after Jan. 1, 2022 (i.e., Jan. 1, 2022 for calendar year plans).

    The No Surprises Act requires group health plans to cover out-of-network emergency services (including emergency services at out-of-network facilities, services and/or items provided by an out-of-network provider at an in-network facility, and out-of-network air ambulance services) without prior authorization and at the plans’ in-network rates. Providers and facilities cannot balance-bill participants for these services. This means that, ultimately, participants will not receive a surprise medical bill after receiving certain emergency services; instead, they will pay their plans’ standard in-network rates regardless of whether they receive such services from in-network or out-of-network providers and regardless of whether such services are provided at in-network or out-of-network facilities.

    In addition, the No Surprises Act establishes a federal dispute resolution process if a provider and a plan cannot agree on the appropriate rate. Before initiating the dispute resolution process, the parties must undergo a 30-day negotiation period to determine the appropriate payment to the provider. If the negotiation is unsuccessful, either party can initiate the federal independent review.

    Additional components of the No Surprises Act, such as the requirements for group health plans to include certain information about deductibles and out-of-pocket maximums on insurance cards and to publicize certain payment rates, have delayed effective and/or enforcement dates. In the interim, plan sponsors of group health plans that are subject to the No Surprises Act should confirm that applicable emergency services are recoded appropriately so that participants are paying the correct rate. In addition, plan sponsors should review their participant communications and update as necessary to clarify when participants pay in-network and out-of-network rates for certain emergency services and when preauthorization is and is not, required.

    Mental Health Parity

    The Mental Health Parity and Addiction Equity Act generally requires that group health plans measure parity across a number of factors with respect to the medical/surgical and mental health and substance use disorder benefits they offer. Specifically, group health plans that provide medical/surgical benefits and mental health or substance use disorder benefits cannot apply a financial requirement or treatment limitation to a mental health or substance use disorder that is more restrictive than the “predominant” financial requirement or treatment limitation applied to substantially all medical/surgical benefits. In addition, these group health plans cannot impose nonquantitative treatment limitations on mental health or substance use disorder benefits unless the standard used in applying such limitation to mental health or substance use disorder benefits is comparable to and applied no more stringently than, the standard used in applying the nonquantitative treatment limitation to medical/surgical benefits (unless recognized clinically appropriate standards of care permit a difference). Examples of nonquantitative treatment limitations include preauthorization requirements and concurrent review.

    Beginning Feb. 10, 2021, under the CAA, regulatory agencies may ask group health plans to provide comparative analyses of their nonquantitative treatment limitations. Although additional guidance is expected, group health plans should review any applicable nonquantitative treatment limitations now and begin gathering any necessary information in case such analysis is requested.

    Health and Welfare Plan Amendments Related to the COVID-19 Pandemic

    Plan sponsors of group health plans that adopted certain changes during 2020 or 2021 as a result of the COVID-19 pandemic (e.g., extending the grace period for unused health and dependent care Flexible Spending Account (“FSA”) funds, increasing the maximum age of eligible dependents for dependent care FSAs, allowing participants to make mid-year changes to their health plan elections without a corresponding change in status event and increasing the annual contribution limit to dependent care FSAs) were required to adopt written plan amendments by Dec. 31, 2021. Additional information about these relief measures can be found in our alerts here. Plan sponsors should review their plan documents to ensure that all documents have been updated appropriately, with all changes communicated to participants.

    Authored by Mark E. Brossman, Ronald E. Richman, Susan E. Bernstein, Max Garfield, Scott A. Gold, Donna K. Lazarus and Melissa J. Sandak.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] For employers that require employees to drive as part of their duties, see CDC’s guidance with respect to marijuana and driving.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    More insights

  • CMS Issues FY 2022 IPPS Final Rule, Implements Medicare GME-Related Provisions

    CMS Issues FY 2022 IPPS Final Rule, Implements Medicare GME-Related Provisions

    ARTICLE / CLIENT ALERT

    CMS Issues FY 2022 IPPS Final Rule, Implements Medicare GME-Related Provisions

    January 7, 2022

    Read time: 10 min

    Key takeaways
    Overview

    In December 2021, the US Centers for Medicare and Medicaid Services (CMS) issued the second part of its FY 2022 Inpatient Prospective Payment System (IPPS) Final Rule with Comment Period. Among other policies, the Final Rule implements three provisions of the Consolidated Appropriations Act of 2021 (CAA) regarding Medicare graduate medical education (GME). The Final Rule also establishes a comment period regarding potential additional rulemaking, including certain uses of health professional shortage area (HPSA) scores in prioritization of additional full-time equivalent (FTE) cap slots and processes for determining eligibility for FTE and per-resident amount (PRA) cap resets.

    In depth

    On December 17, 2021, the Centers for Medicare and Medicaid Services (CMS) released the second part of the Fiscal Year (FY) 2022 Inpatient Prospective Payment System (IPPS) Final Rule with Comment Period (Final Rule), which, among other things, implemented three provisions of the Consolidated Appropriations Act of 2021 (CAA) related to Medicare graduate medical education (GME). Specifically, as to the Medicare GME provisions, the Final Rule outlines parameters governing the distribution of 1,000 new Medicare-funded physician residency slots to qualifying hospitals; provides a process through which teaching hospitals can establish new full-time equivalent (FTE) resident caps or per-resident amounts (PRAs); and details changes to rules for Rural Training Track (RTT) programs.

    Distribution of Additional Medicare-Funded Residency Slots

    Section 126 of the CAA requires CMS to distribute 1,000 new FTE resident cap slots to qualifying hospitals over five-year period beginning in FY 2023. Under the Final Rule, CMS will make 200 residency slots available per year, beginning in 2023, until all 1,000 slots have been allocated. Although the proposed rule would have limited a hospital’s annual award to one FTE residency slot, in response to commentary CMS modified this proposal in the Final Rule to allow for a range of one to five FTE slots to be awarded per hospital per year. The number of slots awarded is determined by the length of the residency program for which the hospital is applying, which is intended to ensure that the hospital is provided with sufficient new FTE cap slots to support the training of residents through the duration of the program.

    Hospitals must apply to be eligible to receive FTE slots, and applications from qualifying hospitals operating residency programs that serve certain geographic areas and underserved populations will be prioritized by using the Health Resource and Services Administration’s health professional shortage areas (HPSAs) score. Specifically, for a hospital to be eligible, it must fall into one of four categories of hospitals:

    • Category 1: located in rural areas or treated as being in a rural area
    • Category 2: training residents over their Medicare GME cap
    • Category 3: located in states with new medical schools or branch campuses on or after January 1, 2000
    • Category 4: that serve areas designated as HPSAs.

    Regarding Category 4 hospitals, CMS initially proposed that a hospital must confirm that more than 50% of residential training time is spent training at the hospital locations within the geographic HPSA. However, under the Final Rule, training that occurs at a program training site located in an HPSA and that treats the HPSA’s population will count toward meeting the 50% training requirement of the category. In addition, psychiatric subspecialty residency programs and psychiatric residency programs are now included within the mental health HPSA category under the Final Rule.

    The application deadline will be March 31 of the year preceding the award year (e.g., applications for 2023 will be due March 31, 2022), instead of the proposed January 31. Hospitals will be notified of any award by January 31 of the award year. The effective date for the additional residency programs will be on July 1 of the award year. Separate applications will be required in each of the five years.

    Along with the application, CMS confirmed that hospitals will need to show a “demonstrated likelihood” that any awarded positions will be filled. As clarified in the Final Rule, this means that CMS will require a hospital to be training residents in excess of its FTE cap and show that it is working to obtain approval (or has already obtained approval) from the appropriate accrediting body to either establish a new residency program or expand an existing residency program. In response to comments, CMS expressly clarified that hospitals that are already operating in excess of their caps would not be able to receive awarded positions on that basis.

    Addressing Low FTE Caps and PRAs

    Historically, some hospitals inadvertently limited their ability to receive Medicare funding for residents in a new training program by accepting residents that rotated to the hospital from established training programs for a short duration, which resulted in the hospital establishing low or zero PRAs or FTE caps. The Final Rule generally confirms CMS’s proposed approach to implementing Section 131 of the CAA and outlines the requirements for resetting PRAs and FTE caps for eligible hospitals.

    Specifically, CMS has identified two categories of eligible hospitals based on its interpretation of the CAA: (1) Category A, which consists of hospitals that have a PRA or FTE cap based on training less than one FTE resident in a cost-reporting period prior to October 1, 1997; and (2) Category B, which refers to hospitals that have a PRA or FTE cap based on training three or fewer FTEs in a cost-reporting period beginning on or after October 1, 1997, and before enactment of the CAA on December 27, 2020. Under the Final Rule, hospitals that are eligible for resets are those that have established an FTE cap or PRA in a cost-reporting year that started prior to enactment of the CAA on December 27, 2020. If a hospital in Category B disagrees with the PRA or FTE cap reported in the applicable base year, and the base year is within the three-year reopening window or is not yet settled, the hospital can initiate a one-time request for reconsideration. However, Category A hospitals are not able to avail themselves of this process.

    Per the Final Rule, a PRA and/or FTE cap reset will be triggered for Category A hospitals when they train at least one FTE, and for Category B hospitals when they train more than three FTEs, in a cost-reporting year beginning after December 27, 2020, but before December 26, 2025. Only training residents in new programs will trigger an FTE cap reset, but training residents in a new program is not a requirement to trigger a PRA reset. Additionally, CMS is no longer requiring that residents be on duty during the first month of the PRA base period for teaching hospitals to receive a PRA reset. This provision also applies to all new teaching hospitals going forward. Otherwise, new FTE caps and PRAs will generally be calculated in the same manner that FTE caps and PRAs are calculated under current rules. (See 42 C.F.R. 413.77(e) (with respect to establishing PRA) and 42 CFR 413.79(e)(1) (with respect to establishing FTE caps).) The Final Rule also provides that the triggering year for the reset will serve as the base year for calculating new PRA determination, although it also provides hospitals the option to instead use the year beginning on or after the issuance of the Final Rule as the base year.

    CMS confirmed that new FTE caps will be added to the hospital’s existing FTE cap. In response to comments, CMS changed its original proposal to disqualify a hospital from being eligible for the FTE cap reset because it started a new program prior to enactment of the CAA, so long as it also starts training residents in a separate new program after the date of enactment. However, CMS will only calculate the adjustment based on the new program that was started after December 27, 2020.

    Going forward, the CAA and Final Rule provide that no FTE cap or PRA will be set for a hospital that trains less than one FTE during a cost-reporting year, which should provide some protection against inadvertently setting low or zero FTE caps and PRAs going forward.

    Creating Flexibility for Rural Training Track

    Additionally, CMS finalized the Promoting Rural Hospital GME Funding Opportunity, which allows certain teaching hospitals participating in RTT programs to receive indirect medical education (IME) and direct graduate medical education (DGME) payment increases. More specifically, previously, a rural track established from an already-existing rural family medicine program would have been ineligible to receive an FTE cap adjustment unless the program was new for Medicare payment purposes. In contrast, if an urban hospital already had an accredited family medicine residency program, it could establish from that existing family medicine program, for the first time, a rural track, and, assuming all applicable requirements were met, that urban hospital could receive IME and DGME FTE resident cap adjustments.

    Under the Final Rule implementing Section 127 of the CAA, CMS allows for FTE cap increases for urban and rural hospitals that participate in a new RTT program, even if the RTT program does not meet the Medicare “newness” criteria. Additionally, the Final Rule describes that urban and rural hospitals will be eligible for adjusted IME and DGME FTE resident caps when additional RTT programs are established after the first program. Previously, an adjustment was only offered for the first RTT program implemented.

    CMS also removed the requirement that an RTT must be separately accredited, so long as the program in its entirety is accredited by the Accreditation Council for Graduate Medical Education and residents in the program, as a whole, spend more than 50% of their training in a rural area. In addition, the Final Rule provides that RTT programs can be in any specialty (whereas previously, only RTT programs specializing in family medicine were permitted).

    Lastly, the final rule exempts residents in RTTs from the three-year rolling average during the five-year cap growth window for RTTs.

    ANALYSIS

    Although CMS received a significant number of comments in response to the 2022 IPPS proposed rule, particularly regarding the distribution of the 1,000 FTE slots under Section 126 of the CAA, these policy changes are overall viewed as positive relief among the teaching-hospital community. CMS described the provisions of the Final Rule implementing Section 126 of the CAA as “…advance[ing] key priorities to close health care equity gaps and enhance the health care workforce in rural and underserved communities” and estimates that the additional funding to hospitals will total approximately $1.8 billion from FY 2023 through FY 2031 (Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System (IPPS) Final Rule with Comment Period (CMS 1752-FC3), December 17, 2021). CMS also views allowing rural teaching hospitals participating in an accredited RTT to receive increases to their FTE caps as making “additional strides to close the health equity gap in rural communities, which tend to experience health care workforce shortages.” (See also the fact sheet linked above). Finally, CMS noted that the provisions of the Final Rule implementing Section 131 advance health equity by allowing these hospitals, which often provide services to otherwise underserved communities, to receive additional residency FTE cap slots and increased PRAs.

    Finally, CMS solicited comments on certain issues to inform potential rulemaking, including:

    1. How to account for healthcare provided outside of an HPSA to HPSA residents, and feasible alternatives to HPSA scores as a proxy for health disparities in the prioritization of additional FTE cap slots.
    2. The review process to determine eligibility for PRA or FTE cap resets in situations where a hospital disagrees with the information on cost reports that are no longer within the three-year reopening period.

    Comments are due by 5 pm EST on February 25, 2022.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Sarah Reis

    Associate

    Boston

    More insights

  • US Secure Equipment Act vs. French Protective Public Policy Framework for Operation of Mobile Radio Networks

    US Secure Equipment Act vs. French Protective Public Policy Framework for Operation of Mobile Radio Networks

    ARTICLE / CLIENT ALERT

    US Secure Equipment Act vs. French Protective Public Policy Framework for Operation of Mobile Radio Networks

    January 7, 2022

    Read time: 7 min

    Key takeaways
    Overview

    Exploring Similarities and Differences

    Fifth-generation technology, known as “5G,” is causing unprecedented upheaval in the telecommunications landscape in France and around the world. Faced with this revolution, and the challenges it presents, France developed through Law 2019-810 a new legal mechanism designed to protect its national security interests in the operation of mobile radio networks. The law focused in particular on the introduction of a new prior authorization regime. Interestingly, in the United States, the recent Secure Equipment Act of 2021 intends to empower the Federal Communications Commission (FCC) to restrict the authorized use of equipment to companies on the agency’s Covered List. In this article, we’ll explore to what extent these two regimes share similarities, and where they differ.

    *McDermott PSL Louis-Nicolas Ricard also contributed to this article.

    In depth

    In France, the law is the result of a proposal by members of parliament in February 2019 which made the observation that whilst the deployment of radio communications networks to ensure digital coverage throughout the national territory of France must be one of the primary objectives of any digital development policy, the deployment of 5G increases the cybersecurity risks associated with network equipment. This is due to 1) the technical specifications of 5G (dynamic management of the access network, introduction of information processing units at the network edge, edge computing) and 2) the use cases of 5G for industrial domains for some critical sectors (e.g. connected / autonomous vehicles, emergent technology, energy networks, etc.). This increased risk places new security requirements on equipment that will support future 5G networks, both in terms of their intrinsic technical characteristics, and in terms of legal obligations that could force their suppliers to cooperate with foreign authorities in the collection of intelligence.

    Considering that 5G technology would carry increased risk compared to previous technologies, the law of August 1, 2019 had at its heart the aim of protecting France’s national security interests in the operation of mobile radio networks. The law added a new article, Article L. 34-11 to the French Post and Electronic Communications Code under which prior authorization from the Prime Minister is required for the operation of certain mobile radio network equipment which, by virtue of their function, “present a risk to the integrity, security and continuity of the network’s operation“. The list of equipment whose operation is subject to an authorization shall be determined by order of the Prime Minister. Under this law, the Prime Minister may refuse to grant authorization for the operation of any hardware or software that allows end-user terminals to be connected to the mobile network as part of the rollout of the 5G network. Among the grounds for refusal are 1) the serious risk of harm to the interests of defense and national security and, 2) the lack of guarantee as to the permanence, integrity, security, and availability of the network. This risk must be assessed where an operator or its service providers may be “under the control of or subject to acts of interference by a non-member state of the Union” (L. No. 2019-810, Aug. 1, 2019, art. 1 amending the second paragraph of Article L. 34-12 of the Post and Electronic Communications Code). To issue authorization, the Prime Minister must take into consideration the level of security of the devices, their deployment and operating methods envisaged by the operator and the extent to which the operator or its service providers, including any subcontractors, are “under the control of or subject to acts of interference by a State that is not a member of the European Union.”

    The law has been challenged before the Constitutional Court, with no success, however some telecommunications companies have directly challenged decisions by the Prime Minister not to grant an authorization, most notably in the case of Huawei. Companies are also seeking damages against the French government to obtain compensation for the costs of replacing equipment that is now banned.

    In the United States, the Secure Equipment Act passed both the House of Representatives and the Senate near unanimously (on a vote of 420 to 4) and was signed almost immediately by President Joe Biden on November 11, 2021.

    This legislation aims to solidify the authority of the FCC, an independent US government agency overseen by Congress responsible for implementing and enforcing America’s communications law and regulations. The FCC regulates interstate and international communications by radio, television, wire, satellite, and cable in all 50 states, the District of Columbia, and all US territories.

    The FCC can now deny equipment authorizations from its “Covered List” of entities, a list of communications equipment and services that are deemed to pose an unacceptable risk to the national security of the United States, or to the security and safety of United States persons. The FCC it is prohibited by this law from reviewing or approving any application for equipment that is on the aforementioned list of covered communications equipment or services.

    In addition, no authorization will be granted by the FCC for equipment offered by the companies on the covered list regardless of what type of funds are used to purchase such equipment.

    This legislation essentially finalizes the legal efforts to protect the nation’s communications networks from security risks. Back in November 2019 the FCC adopted a ban on the use of Universal Service Fund (USF) support to purchase, obtain, or maintain any equipment or services from companies posing a national security threat to communications networks or the communications supply chain. This ban enforced the Secure Networks Act, enacted in 2020 under the Trump administration, which prohibited the use of federal subsidies for covered communications equipment and services. Before that, Congress passed and the President signed into law in 2017 and 2018, a series of National Defense Authorization Acts (NDAA) which specifically stated that government agencies could not “procure or obtain or extend or renew a contract to procure or obtain any equipment, system, or service that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system.”

    The United States has also doubled down on this protection of national cybersecurity with efforts in its international relations. For example, the United States declared that it would stop sharing information with allies that allow Huawei to supply a significant part of its telecommunications infrastructure, claiming that the security risk was too great.

    It may also be of interest to note that the Secure Equipment Act came just after the FCC’s decision to revoke the authorization for China Telecom’s US subsidiary to operate in the United States, citing national security concerns. In its press release, the FCC said it “adopted an order ending China Telecom (Americas) Corporation’s ability to provide domestic interstate and international telecommunications services within the United States”, explaining such “action carries out [the FCC’s] mission to safeguard the nation’s telecommunications infrastructure from potential security threats.” In order to assist US customers with transitioning to other mobile service providers as a result of China Telecom Americas’ discontinued services, the FCC did issue a consumer guide after the Order was released that explains this decision and what other options consumers might consider for mobile services.

    Both the US and French regimes have the same effect; ensuring that technology is safe for consumers and does not threaten national security. Both will develop with time, and as new technology emerges there are already calls for stricter regulation on, for example, component parts. Governments around the world will be watching the development of both legal regimes closely, perhaps to draw inspiration for adopting similar measures. However, in France, the scrutiny on the implementation of such regime will continue as the Prime Minister’s decisions continue to be challenged on various grounds.

    Authors

    Sabine Naugès

    Partner

    Paris

    More insights

  • Proposed New Code Sec. 163(n) and Removal of Expense Allocation to GILTI

    Proposed New Code Sec. 163(n) and Removal of Expense Allocation to GILTI

    ARTICLE

    Proposed New Code Sec. 163(n) and Removal of Expense Allocation to GILTI

    November-December 2021

    Read time: 8 min

    Key takeaways
    Overview

    This column describes new proposed Code Sec. 163(n) and the proposed general removal of expense allocation to GILTI in the Build Back Better Act (the “BBBA”). This column focuses on the version of the BBBA proposed on November 3, 2021.

    In depth

    General Removal of Expense Allocation to GILT I
    The BBBA would largely remove expense allocation to GILTI for foreign tax credit purposes. More specifically, the BBBA would replace Code Sec. 904(b)(4), which would provide that in the case of a domestic corporation and solely for purposes of the foreign tax credit limitation in Code Sec. 904(a) with respect to amounts described in Code Sec. 904(d)(1)(A) (GILTI category income), the taxpayer’s taxable income from sources without the United States is determined by allocating and apportioning any deduction allowed under Code Sec. 250(a)(2) (and any deduction allowed under Code Sec. 164(a)(3) for taxes imposed on amounts described in Code Sec. 250(a)(2)) to such income. In addition, other deductions may be allocated and apportioned to such GILTI category income only if the Secretary determines that such deduction is directly allocable to such income. Any deduction which would, but for the rules described above, have been allocated or apportioned to GILTI category income would only be allocated or apportioned to income which is from sources within the United States (and would not be allocable and apportioned, for example, to foreign source, general category income). Subject to very limited exceptions, this would effectively repeal the allocation and apportionment of expenses to GILTI for foreign tax credit purposes. As previously discussed, allocation and apportionment of expenses to GILTI category for foreign tax credit purposes limits the utilization of foreign tax credits with respect to GILTI and often results in U.S. tax on GILTI, even if the foreign tax rate is above 13.125 percent.

    Addition of Proposed Code Sec. 163(n)
    The BBBA would add new Code Sec. 163(n), which would cap the amount of deduction for interest expense (that exceeds interest income) at the “allowable percentage” of 110 percent of such excess. The allowable percentage is the domestic corporation’s “allocable share” of the group’s reported net interest expense (as reported in an applicable financial statement) over such corporation’s reported net interest expense (as reported in books and records in preparing such group’s applicable financial statement). The allocable share of the group’s reported net interest expense is the group’s reported net interest expense times the ratio of the domestic corporation’s EBITDA to the EBITDA of the group. The worse of the limit under Code Sec. 163(j) or Code Sec. 163(n)(1) applies.

    Code Sec. 163(n) is applicable to a domestic corporation which is a member of a multinational group that prepares consolidated financial statements, and which has averaged net interest expense for the three-year reporting period of more than $12 million annually. Unlike prior proposals that would be limited to U.S. subsidiaries of foreign-parented groups, the BBBA’s version of Code Sec. 163(n) would apply to U.S. corporations of both foreign-parented and U.S.-parented groups.

    Under new Code Sec. 163(o), the amount of any interest not allowed as a deduction by reason of Code Sec. 163(j) or (n)(1) (whichever imposes the lower limitation with respect to such taxable year) is treated as paid or accrued in the succeeding taxable year (with an unlimited carryforward period).

    As an example, assume USCo’s EBITDA comprises 50 percent of the EBITDA of the group, and the group has $100 of reported net interest expense (as reported in its Form 10-K). Also assume that USCo has $100 of reported net interest expense (as reported in books and records in preparing the group’s Form 10-K) and $100 of net interest expense for U.S. tax purposes. USCo’s allocable share of the group’s reported net interest expense would be $50 (EBITDA of USCo/EBITDA of group × group reported net interest expense of $100). The allowable percentage would also be 50 percent (USCo’s allocable share of the group’s reported net interest expense of $50/USCo’s reported net interest expense of $100). Thus, Code Sec. 163(n) would limit the interest expense to $55 (allowable percentage of 50 percent × 110 percent × $100 net interest expense for U.S. tax purposes), and $45 of interest expense is carried forward to the following year.

    The Trade-Off
    Although the addition of Code Sec. 163(n) is not framed as a replacement of expense allocation to GILTI, the two provisions are loosely correlated. For taxpayers that have excess taxes in the GILTI category, expense allocation effectively disallows a deduction for interest expense for every dollar of interest expense allocated and apportioned to GILTI category income. As previously discussed, because GILTI is essentially a full-inclusion system, it is odd to effectuate U.S. tax rates on foreign subsidiary income through the foreign tax credit system, especially given that expense allocation often results in taxing high-taxed income, rather than low-taxed income. In contrast, Code Sec. 163(n) provides for a direct disallowance of a deduction for interest expense. Lawmakers may have also viewed a direct disallowance approach as more administrable than expense allocation in the context of a move to applying Code Sec. 904(a) limitation on a country-by-country, taxable unit basis. The move to country-by-country limitation and country-by-country GILTI will be enormously complex, even without unnecessary complications from expense allocation.

    Business Implications
    Generally, Code Sec. 163(n) will adversely impact large U.S. taxpayers with significant (third-party or related-party) debt, and the corporate group which includes the U.S. taxpayer has significant foreign operations. Code Sec. 163(n) increases the cost of debt financing for these U.S. companies, and particularly impacts U.S. companies in industries that rely on debt financing. The impact of Code Sec. 163(n) could be significant. For instance, in the simple example above, nearly half of the interest expense incurred by the U.S. corporation is disallowed in the year (without regard to whether the U.S. corporation is thinly capitalized or not). If a prospective new investment in the United States were to be financed in part by new debt by a U.S. member of the group, nearly half the interest rate for that prospective investment would be disallowed under the simple facts above, increasing the hurdle rate for profitability.

    Unlike Code Sec. 163(j), foreign jurisdictions do not have a provision anything like Code Sec. 163(n). Many of the international tax proposals in BBBA are intended to line up with the OECD’s Pillar 2 framework (such as the move to country-by-country), and the OECD Pillar 2 framework does not include a provision similar to Code Sec. 163(n). Tax is one out of many considerations, and Code Sec. 163(n) could in certain circumstances nudge towards offshore borrowing, either through offshore third-party borrowing or the U.S. company on-lending the proceeds to foreign affiliates.

    Deference to Financial Accounting
    One interesting aspect of new Code Sec. 163(n) is its deference to financial accounting in computing interest deduction disallowance for U.S. federal income tax purposes. For example, as noted above, a corporation’s “allocable share” of the group’s reported net interest expense is based on the ratio of the EBITDA of the corporation over the EBITDA of the group. EBITDA means EBITDA5 as determined in the group’s financial statements (such as the Form 10-K), or as determined in the books and records of the group which are used in preparing such statements. Thus, EBITDA for this purpose means EBITDA as determined for financial accounting purposes. Similarly, “reported net interest expense” is determined under financial accounting rules. However, financial accounting is designed to address policies different from U.S. tax principles, and there could be intentional differences between the financial accounting treatment and the U.S. tax treatment of interest income, interest expense, or EBITDA. The impact of the deference to financial accounting for tax purposes is highly important in the proposed 15-percent minimum tax on “adjusted financial statement income”.

    To alleviate these issues, Code Sec. 163(n)(7) provides the Secretary may issue such regulations or other guidance as are necessary or appropriate to carry out the purposes of Code Sec. 163(n), including, among other things, regulations or other guidance which allows or requires the adjustment of amounts reported on applicable financial statements. It remains to be seen how, and to the extent, Treasury would exercise its authority under Code Sec. 163(n)(7).

    Effective Date
    The changes to expense allocation and Code Secs. 163(n) and (o) apply to taxable years beginning after December 31, 2022.

    Conclusion
    To better understand the tax impact of Code Secs. 163(n) and (o), taxpayers may want to better understand the reporting of interest expense, interest income, and EBITDA for financial accounting purposes. Taxpayers should model the impact of new Code Secs. 163(n) and (o) and the general removal of expense allocation to determine the impact of these changes on their particular facts.

    Authors

    Caroline H. Ngo

    Partner

    Washington, DC

    More insights

  • Can’t Overturn Jury Verdicts Based on Reasonable Inferences, but Broad Injunction Is Nonstarter Even for Willfully Misappropriated Trade Secrets

    Can’t Overturn Jury Verdicts Based on Reasonable Inferences, but Broad Injunction Is Nonstarter Even for Willfully Misappropriated Trade Secrets

    ARTICLE

    Can’t Overturn Jury Verdicts Based on Reasonable Inferences, but Broad Injunction Is Nonstarter Even for Willfully Misappropriated Trade Secrets

    January 6, 2022

    Read time: 4 min

    In a rare appellate trade secret opinion, the US Court of Appeals for the Eleventh Circuit affirmed a district court’s denial of a defendant’s request for a new trial on liability and its refusal of the plaintiff’s requested injunction. It also reversed in part the district court’s denial of judgment as a matter of law (JMOL) on damages for clear error because the plaintiff failed to deduct marginal costs when calculating lost profits. Financial Information Technologies v. iControl Systems, Case No. 20-13368 (11th Cir. Dec. 22, 2021) (Jordan, Newsom, JJ., and Burke, Distr J.).

    Competitors Financial Information Technologies (Fintech) and iControl Systems both sell software that processes alcohol sales invoices within 24 hours. Fintech was a lone operator for several years until iControl started servicing the alcohol industry and began selling a very similar product at a lower price point. After Fintech lost its vice president of operations (who was very involved in designing Fintech’s software), a sales representative and several customers to iControl, Fintech filed suit alleging misappropriation of trade secrets. The jury ruled in Fintech’s favor and awarded compensatory and punitive damages. iControl sought a new trial on liability, contending that Fintech’s alleged trade secrets were readily ascertainable and not “secret,” and JMOL on damages since Fintech hadn’t proved lost profits because it hadn’t deducted fixed and marginal costs from its lost revenue calculations. Fintech sought a permanent injunction prohibiting iControl from using either company’s software. The district court denied all three motions, and both parties appealed.

    As to the jury verdict, the Eleventh Circuit noted that jury liability findings are generally difficult to overturn, and that the verdict was general and nonspecific regarding which of the seven alleged trade secrets iControl had misappropriated, so Fintech only needed to show evidence under the Florida Uniform Trade Secrets Act (FUTSA) of misappropriation as to one. iControl also did not move for JMOL on liability, and therefore, under the abuse-of-discretion standard of review, the Court could only overturn if “there is an absolute absence of evidence to support the verdict.” However, the Court found that Fintech and its witness presented sufficient evidence at trial to permit a reasonable jury to find that Fintech possessed at least one of the seven alleged trade secrets and that it was misappropriated. The evidence included emails indicating that its former vice president helped iControl discover Fintech’s internal processes to aid software developments, assisted iControl’s chief technology officer in troubleshooting issues in a manner similar to Fintech, shared screenshots of Fintech’s user portal and prompted customers to switch to iControl.

    Similarly, the Eleventh Circuit found that the jury reasonably could have inferred from the evidence that iControl schemed to hire Fintech employees to misappropriate Fintech’s software features—an act that demonstrated willfulness.

    After assessing the meanings of fixed and marginal costs and the properly fact-intensive revenue and profits figures of the businesses, the Eleventh Circuit agreed that the jury was not required to deduct Fintech’s fixed costs from its revenues to arrive at a proper “actual loss” measure but found no evidence from which the jury could have reasonably found that Fintech’s marginal costs were zero. Thus, on remand the district court should require an accounting of marginal costs for a proper lost-profits calculation.

    As for the requested injunction, Fintech argued that its proposed remedy was reasonably tailored to restrain iControl’s misappropriation, but the Eleventh Circuit disagreed. Fintech had sought a blanket injunction prohibiting iControl from doing business in the regulated commerce industry, which the district court correctly denied since FUTSA only “authorizes the injunction of specific, identifiable trade secrets,” not “blanket restraint of competition” or injunction “as a vehicle to restrict competition.” Fintech’s revised proposal was to prohibit iControl from using Fintech’s proprietary regulated commerce software and iControl’s Harmony software and Next Gen Reconciliation software, which Fintech argued misappropriated its proprietary method and process for developing and including information in its case and reporting features. The Court agreed that even this scope was an impermissible restraint that “swe[pt] too broadly and promoted confusion about the nature of Fintech’s trade secrets,” particularly when the jury verdict was not specific regarding which trade secret had been violated.

    More insights

  • Sixth Circuit Holds State Court Tax Foreclosure Subject to Fraudulent Transfer Attack

    Sixth Circuit Holds State Court Tax Foreclosure Subject to Fraudulent Transfer Attack

    ARTICLE / CLIENT ALERT

    Sixth Circuit Holds State Court Tax Foreclosure Subject to Fraudulent Transfer Attack

    January 6, 2022

    Read time: 7 min

    Key takeaways
    Overview

    A “federal [fraudulent transfer claim under Bankruptcy Code § 548] is independent of [a] state-court [foreclosure] judgment,” held the U.S. Court of Appeals for the Sixth Circuit on Dec. 27, 2021. In re Lowry, 2021 WL 6112972, *1 (6th Cir. Dec. 27, 2021). Reversing the lower courts’ approval of a Michigan tax foreclosure sale, the Sixth Circuit reasoned that “the amount paid on foreclosure bore no relation at all to the value of the property, thus precluding the … argument that the sale was for ‘a reasonably equivalent value’ under the rule of BFP v. Resolution Trust Corp., 511 U.S. 531, 544-45 (1994) [(reasonably equivalent value is the price actually received for the property at a foreclosure sale, so long as that sale satisfied all the requirements of state foreclosure law)]. Accordingly, the court remanded the case for “consideration of further arguments not fully developed below.”

    Relevance

    Courts have been split on whether the BFP rule applies to local tax foreclosures — i.e., whether a tax foreclosure can be avoided as a fraudulent transfer. See, e.g., In re Grandote Country Club Co., Ltd., 252 F.3d 1146, 1152 (10th Cir. 2001) (tax sale upheld) (“Although BFP did not address a tax sale … BFP has been extended to the tax sale context … .[T]he decisive factor in determining whether a transfer pursuant to a tax sale constitutes ‘reasonably equivalent value’ is a state’s procedure for tax sales, in particular, statutes requiring that tax sales take place publicly under a competitive bidding procedure.”); In re Lindsay, 59 F.3d 942, 949 (9th Cir. 1995) (tax sale “complied with Texas law,… was noncollusive, and notice was proper… foreclosure stands”); contra, In re Smith, 811 F.3d 228, 234 (7th Cir. 2016) (“… the reasoning of BFP does not extend to Illinois tax sales … .”); In re GGI Props., LLC, 568 B.R. 231 (Bankr. D.N.J. 2017) (pre-bankruptcy tax foreclosure sale conducted in accordance with New Jersey law which did not provide for advertising or competitive bidding, and which allowed taxing authority to acquire tax sale certificates at conclusion of auction when no bids were received, did not conclusively establish reasonably equivalent value; transfer of property to municipality pursuant to tax sale and foreclosure, when there was no competitive bidding, can constitute fraudulent transfer); but see Gunsalus v. Ontario County, NY, 576 B.R. 302 (Bankr. W.D. N.Y. 2017) (“Reasonably equivalent value” conclusively presumed at regular non-collusive tax foreclosure sale). State taxing authorities need revenue and want finality in their foreclosure sales. On the other hand, though, neither creditors nor the taxing authorities should want a property sold for a fraction of its value, as was the case in Lowry.

    Facts

    The debtor in Lowry owned a home in Michigan and failed to pay his property taxes for years. The county foreclosed on the home and a city bought the property for the amount of outstanding taxes due, without a public auction, with the statutory “minimum bid” of $14,486. But the debtor claimed that the property had “a fair market value of $152,000 at the time of the foreclosure.” Lowry, 2021 WL 6112972, at *2.

    The bankruptcy court dismissed the fraudulent transfer complaint filed by the debtor and the subsequent buyer of the property who had paid “one dollar” for it. Id. According to the bankruptcy court, the debtor was merely attempting to relitigate the foreclosure proceedings in the state court and the BFP rule “should extend to tax foreclosures in Michigan.” Id. Affirming the bankruptcy court, the district court held that the Rooker-Feldman doctrine[1] “barred review [because the debtor’s] appeal would require the court to revisit a fully-litigated state court decision,” characterizing the debtor’s arguments as “nothing more than an attempt to gain a review of the state court’s ruling.” Id. at *3.

    Sixth Circuit Analysis

    Rooker-Feldman did not apply, held the Sixth Circuit, because the “alleged injury … is not the state court foreclosure judgment, but instead is the fact that the debtor could not use [Code] § 548 to avoid the foreclosure as a fraudulent transfer. Although the § 548 [fraudulent transfer] issue is closely related to the state foreclosure judgement, that by itself does not mean that Rooker-Feldman applies.” Id.

    More important, the Sixth Circuit held that “BFP does not apply to the facts of this case.” Id. at *4. In BFP, the Supreme Court reasoned that “if state law is followed in a mortgage foreclosure sale, the debtor cannot use § 548 to avoid the foreclosure as a fraudulent transfer.” Id. In contrast, however, “this case involves a tax foreclosure, not a mortgage foreclosure, and in BFP the Court explicitly declined to decide whether the rule applied to tax foreclosures, limiting its opinion to cover ‘only mortgage foreclosures of real estate.’“ 511 U.S. at 537 n.3. In fact, the Supreme Court noted that the “considerations bearing upon other foreclosures and forced sales (to satisfy tax liens, for examples) may be different.” Id.

    The tax foreclosure process in Lowry was “significantly different from the mortgage foreclosure system in BFP. The debtor’s home in BFP was sold for $433,000 in a foreclosure sale that provided sufficient procedural protections under state law.” Lowry, 2021 WL 6112972, at *4, citing 511 U.S. at 534, 541-42, 545-46. In Lowry, though, “the Michigan foreclosure law … permitted the local government to purchase the property, without a public auction, for the ‘minimum bid.’“ Id. The city’s purchase of the property was for a “an amount that had no apparent relation to the value of the property and was only about ten percent of the alleged fair-market value.” Id. The “Michigan law also permitted the foreclosing government authority to retain the ‘surplus proceeds’ from a foreclosure sale,” making it “thus distinguishable from the mortgage foreclosure process … in BFP.” Id.

    In sum, the Michigan tax foreclosure sale turned “on the value of the taxes owed rather than the value of the property.” Id. Accord, In re Smith, 891 F.3d 228, 234 (7th Cir. 2016) (BFP did not extend to Illinois state court tax foreclosure because the “lowest bid wins, and the bid amounts bear no relationship to the value of the underlying real estate;” no competitive bidding; “bidders bid how little money they are willing to accept in return for payment of the owner’s delinquent taxes.”) (emphasis in original).

    The Sixth Circuit remanded the issue in Lowry to the district court because of an insufficient record on appeal. First, the lower courts never decided the “threshold issue of whether [the debtor] satisfies the insolvency requirement of [Code] § 548[(a)(1)(B)(ii)],” an essential element of a constructive fraudulent transfer claim. Nor did the parties develop other unrelated issues in the lower courts.

    Comment

    The Sixth Circuit in Lowry, like the Seventh in Smith, focused on the particular state tax foreclosure procedure. Did it did permit a public auction? Competitive bidding? Broad notice? Concern for the property’s value? And if the debtor in Lowry is found to have been solvent, the fraudulent transfer issue is moot.

    Authored by Michael L. Cook.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Rooker v. Fidelity Trust Co., 263 U.S. 413 (1923), and D.C. Court of Appeals v. Feldman, 460 U.S. 462 (1983) (federal courts should not review state court decisions unless authorized by Congress to do so).


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • A Mammoth Project for Many Years – On new ESG requirements for investors

    ARTICLE

    A Mammoth Project for Many Years – On new ESG requirements for investors

    December 24, 2021

    Read time: 2 min

    Key takeaways
    Overview

    Delays can be expensive

    Frank Müller with an article on the new ESG requirements for investors and what asset managers, fund initiators and investors have to prepare for.

    In depth
    Authors

    Frank Müller

    Partner

    Frankfurt

    More insights